Search
for
Sort by
Research 31–60 of 499
- Adverse Cutaneous Reactions to Antidepressants
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- Anticonvulsant-Induced Cutaneous Reactions
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- Spontaneous cutaneous adverse drug reaction reports—An analysis of a 10‐year dataset in Singapore
- Psychoactive drugs and skin
- Psychotropic Medications and the Skin
- Chemotherapy and Cutaneous Drug Reactions
- Chemotherapy and the Skin: Understanding Dermatologic Side Effects
- Taiwanese Dermatological Association consensus for the prevention and management of epidermal growth factor receptor tyrosine kinase inhibitor-related skin toxicities
- Cutaneous Side Effects of Chemotherapy and Radiotherapy
- Adverse Cutaneous Reactions to Antipsychotics
- Iododerma in pregnancy secondary to iodinated multivitamins
- Targeted Therapy– and Chemotherapy-Associated Skin Toxicities: Systematic Review and Meta-Analysis
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Dermatologic Side Effects of Systemic Targeted Anticancer Therapy
- Lithium therapy associated with hidradenitis suppurativa: Case report and a review of the dermatologic side effects of lithium
- Adverse Reactions to Biologic Medications Used in Allergy and Immunology Diseases
- Efficacy and Skin Toxicity Management with Cetuximab in Metastatic Colorectal Cancer: Outcomes from an Oncologic/Dermatologic Cooperation
- Cutaneous drug reactions
- A Case of Cicatricial Alopecia Associated with Erlotinib
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- IL-36γ drives skin toxicity induced by EGFR/MEK inhibition and commensal Cutibacterium acnes
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Morphological characteristics and notes of the skin in preclinical toxicity assessment
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
- Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management
- Management of Dermatologic Toxicities
- Fatal Toxic Epidermal Necrolysis Associated With Cetuximab in a Patient With Colon Cancer